Artículos de opinión
Evaluación económica de medicamentos: experiencias y vías de avance
Economic drug evaluation: experiences and pathways to progress
José Antonio Sacristána,
, Tatiana Dillaa, José Luis Pintob, Fernando Antoñanzasc
Corresponding author
sacristan-jose@lilly.com
Correspondencia: José Antonio Sacristán. Departamento de Investigación Clínica, Lilly. Avda. de la Industria, 30. 28108 Alcobendas. Madrid. España.
Correspondencia: José Antonio Sacristán. Departamento de Investigación Clínica, Lilly. Avda. de la Industria, 30. 28108 Alcobendas. Madrid. España.
Read
1866
Timeswas read the article
570
Total PDF
1296
Total HTML
Article information
ISSN: 02139111Original language: Spanish
DOI:10.1157/13125358
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 11 | 5 | 16 |
| 2025 5 | 92 | 27 | 119 |
| 2025 4 | 85 | 29 | 114 |
| 2025 3 | 82 | 28 | 110 |
| 2025 2 | 89 | 25 | 114 |
| 2025 1 | 71 | 33 | 104 |
| 2024 12 | 71 | 22 | 93 |
| 2024 11 | 67 | 35 | 102 |
| 2024 10 | 73 | 30 | 103 |
| 2024 9 | 43 | 25 | 68 |
| 2024 8 | 64 | 23 | 87 |
| 2024 7 | 39 | 22 | 61 |
| 2024 6 | 49 | 20 | 69 |
| 2024 5 | 59 | 29 | 88 |
| 2024 4 | 40 | 16 | 56 |
| 2024 3 | 44 | 19 | 63 |
| 2024 2 | 40 | 46 | 86 |
| 2024 1 | 43 | 19 | 62 |
| 2023 12 | 25 | 11 | 36 |
| 2023 11 | 31 | 18 | 49 |
| 2023 10 | 33 | 14 | 47 |
| 2023 9 | 31 | 11 | 42 |
| 2023 8 | 30 | 18 | 48 |
| 2023 7 | 35 | 21 | 56 |
| 2023 6 | 33 | 13 | 46 |
| 2023 5 | 16 | 11 | 27 |
Show all
